Editorial|Volume 10, Issue 1|pp 11—12 Targeting LSD2 in breast cancer
Yi Huang1,Women’s Cancer Research Center, UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA2Department of Pharmacology & Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA, Yongmei Yin3Department of Oncology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, P.R. China, Min Sun1,Women’s Cancer Research Center, UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA4UPMC St. Margaret Hospital, Pittsburgh, PA 15215, USA
- 1Women’s Cancer Research Center, UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA
- 2Department of Pharmacology & Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA
- 3Department of Oncology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, P.R. China
- 4UPMC St. Margaret Hospital, Pittsburgh, PA 15215, USA
Received: January 11, 2018Accepted: January 19, 2018Published: January 20, 2018
Copyright: © 2018 Huang et al.
This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
